Effectiveness of DIR/Floortime™ in Children With Intellectual Developmental Disorder
DIR-IDD
1 other identifier
interventional
24
1 country
1
Brief Summary
This randomized controlled trial aims to evaluate the effectiveness of Integrated Developmental, Individual-differences, Relationship-based (DIR)/Floortime™ intervention in improving functional emotional development and adaptive behavior in children with Intellectual Developmental Disorder (IDD). Participants aged 4-12 years will be randomly assigned to receive either DIR/Floortime™ in addition to standard therapy or standard therapy alone for 10 weeks. Outcomes will be assessed using the Functional Emotional Assessment Scale (FEAS) and the Vineland Adaptive Behavior Scales (VABS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
CompletedFirst Submitted
Initial submission to the registry
August 6, 2026
CompletedFirst Posted
Study publicly available on registry
August 11, 2026
CompletedAugust 13, 2026
August 1, 2026
4 months
August 6, 2026
August 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Communication Skills
Change in Communication Skills measured using the Vineland Adaptive Behavior Scales, Third Edition (VABS-3), Communication domain Growth Scale Values (GSVs). GSVs range from 10 to 197, with higher scores indicating better adaptive functioning.
Baseline and Week 10
Socialization Skills
Change in Socialization Skills measured using the Vineland Adaptive Behavior Scales, Third Edition (VABS-3), Socialization domain Growth Scale Values (GSVs). GSVs range from 10 to 197, with higher scores indicating better adaptive functioning.
Baseline and Week 10
Daily Living Skills
Change in Daily Living Skills measured using the Vineland Adaptive Behavior Scales, Third Edition (VABS-3), Daily Living Skills domain Growth Scale Values (GSVs). GSVs range from 10 to 197, with higher scores indicating better adaptive functioning.
Baseline and Week 10
Functional Emotional Development
Change in functional emotional development measured using the Functional Emotional Assessment Scale (FEAS). FEAS items are scored from 0 to 2, with higher scores indicating better functional emotional development. Symbolic, Sensory, and Examiner scores are assessed.
Baseline and Week 10
Study Arms (2)
DIR/Floortime + Standard Therapy
EXPERIMENTALParticipants receive Integrated DIR/Floortime™ in addition to their routine standard therapeutic services for 10 weeks.
Standard Therapy
ACTIVE COMPARATORParticipants continue to receive routine standard therapeutic services without the addition of DIR/Floortime™ for 10 weeks.
Interventions
Integrated Developmental, Individual-differences, Relationship-based (DIR)/Floortime™ intervention delivered for 10 weeks in addition to standard therapy
Routine therapeutic services provided without DIR/Floortime™ during the 10-week study period.
Eligibility Criteria
You may qualify if:
- Children aged 4-12 years.
- Clinical diagnosis of Intellectual Developmental Disorder (IDD) according to DSM-5-TR criteria.
- Mild to moderate intellectual developmental impairment.
- Receiving routine therapeutic services.
- Able to participate in the 10-week DIR/Floortime™ intervention and study assessments.
- Written informed consent obtained from a parent or legal guardian.
You may not qualify if:
- Profound or severe Intellectual Developmental Disorder preventing meaningful participation in the intervention.
- Severe visual, hearing, or physical impairments that would interfere with assessments or intervention.
- Major neurological or genetic disorders that could affect study participation.
- Serious medical or psychiatric conditions requiring intensive treatment.
- Participation in another intervention study during the study period.
- Parent or legal guardian unwilling to provide written informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- GIFT Universitylead
Study Sites (1)
SEND Therapy Center
Gujranwala, Punjab Province, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle investigator
Study Record Dates
First Submitted
August 6, 2026
First Posted
August 11, 2026
Study Start
March 16, 2026
Primary Completion
July 15, 2026
Study Completion
August 1, 2026
Last Updated
August 13, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Individual Participant Data (IPD) will not be shared. The study involves confidential data from children with Intellectual Developmental Disorder, and participant privacy and confidentiality will be protected in accordance with institutional ethical approval and informed consent.